Universitätsklinikum Göttingen

Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases (2025) Mravinacová S, Bergström S, Olofsson J, de San José NG, Anderl-Straub S, Diehl-Schmid J, Fassbender K, et al. Journal article Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study) (2025) Wilsmann-Theis D, Patt S, Pinter A, Gerdes S, Magnolo N, Németh R, Schmitz J, et al. Journal article Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma (2025) Reitmajer M, Livingstone E, Thoms KM, Heppt M, Meiss F, Gesierich A, Drexler K, et al. Journal article The ‘MOAHLFA(P) Index’: An Attempt to Standardise a Widely Used Array of Descriptors of Patch-Tested Patients (2025) Uter W, Andersen KE, Brans R, Bruze M, Schubert S, Gonçalo M, Aalto-Korte K, et al. Journal article Urinary Dickkopf-related protein 3 as a novel biomarker for kidney function decline in children with Alport syndrome (2025) Boeckhaus J, Tönshoff B, Weber LT, Pape L, Latta K, Fehrenbach H, Lange-Sperandio B, et al. Journal article Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients (2024) Weishaupt JH, Körtvélyessy P, Schumann P, Valkadinov I, Weyen U, Hesebeck-Brinckmann J, Weishaupt K, et al. Journal article Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study (2024) Linse K, Weber C, Reilich P, Schöberl F, Boentert M, Petri S, Rödiger A, et al. Journal article Which Comprehensive Geriatric Assessment (CGA) instruments are currently used in Germany: a survey (2024) Kudelka J, Ollenschläger M, Dodel R, Eskofier B, Hobert MA, Jahn K, Klucken J, et al. Journal article Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy (2024) Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, et al. Journal article Interactive exploration of adverse events and multimorbidity in CKD. (2024) Steinbrenner I, Kotsis F, Kosch R, Meiselbach H, Bärthlein B, Stockmann H, Lipovsek J, et al. Journal article